Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2959-2959
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The microbiota and the gut–liver axis in primary sclerosing cholangitis
Johannes R. Hov, Tom H. Karlsen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 135-154
Closed Access | Times Cited: 53
Osteopontin characterizes bile duct–associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis
Kevin De Muynck, Lander Heyerick, Federico F. De Ponti, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 269-288
Closed Access | Times Cited: 23
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 22
Exploring the potential of treating chronic liver disease targeting the PI3K/Akt pathway and polarization mechanism of macrophages
Yaqian Yang, Xiao-Tao Jia, mengyang qu, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17116-e17116
Open Access | Times Cited: 18
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis
Naqash Alam, Linying Jia, Ao Cheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 5
Transport of tryptophan dipeptide derivatives and impact on inflammatory cytokines in monocyte/macrophage-like cells.
Jae B. Park, Renee Peters
Heliyon (2025) Vol. 11, Iss. 5, pp. e43000-e43000
Open Access
Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction
Samira Farhadi, Saeed Mohammadi, Abdulaziz Alkindi, et al.
World Journal of Biological Chemistry (2025) Vol. 16, Iss. 1
Open Access
Inflammasome and pyroptosis in autoimmune liver diseases
Jixuan Wang, Zhiwen Sun, Jingri Xie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
Galectins and Liver Diseases
Shima Mimura, Asahiro Morishita, Kyoko Oura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 790-790
Open Access
Neutrophil extracellular traps (NETs) and NETosis in alcohol‐associated diseases: A systematic review
Mohammed A. S. Khan, Byoung‐Joon Song, Xin Wang, et al.
Alcohol Clinical and Experimental Research (2025)
Closed Access
Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice
Virender Kumar, Bharti Sethi, Dalton W. Staller, et al.
Biomaterials (2023) Vol. 295, pp. 122049-122049
Open Access | Times Cited: 11
Macrophages and the development and progression of non-alcoholic fatty liver disease
Bader Alabdulaali, Fatema Al‐Rashed, Mohammed Al‐Onaizi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis
Suhong Xia, Yujie Huang, Yu Zhang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis
Kevin De Muynck, Bart Vanderborght, Federico F. De Ponti, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 4, pp. 366-379
Open Access | Times Cited: 9
Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte‐derived cells does not alter the induction or progression of hepatocellular carcinoma
Bart Vanderborght, Kevin De Muynck, Eva Gijbels, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 12, pp. 2615-2628
Open Access | Times Cited: 4
Jian Gan powder ameliorates immunological liver injury in mice by modulating the gut microbiota and metabolic profiles
Kun Li, Yadong Cui, Xue Zheng, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Gut Microbiota and Liver Regeneration: A Synthesis of Evidence on Structural Changes and Physiological Mechanisms
Yana V. Kiseleva, Т. С. Жарикова, Roman Maslennikov, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 6, pp. 101455-101455
Closed Access | Times Cited: 1
Liver Macrophage Diversity in Health and Disease
Paul Horn, Frank Tacke
Results and problems in cell differentiation (2024), pp. 175-209
Closed Access | Times Cited: 1
Plasticity of monocytes and macrophages in cirrhosis of the liver
Anne Geng, Emilio Flint, Christine Bernsmeier
Frontiers in Network Physiology (2022) Vol. 2
Open Access | Times Cited: 7
Metagenomic signatures reveal the key role of phloretin in amelioration of gut dysbiosis attributed to metabolic dysfunction-associated fatty liver disease by time-dependent modulation of gut microbiome
Jyoti Chhimwal, Prince Anand, Priyanka Mehta, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry
Lotta Elonen, Lena Wölfle, Jan de Laffolie, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 4
Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases
Ziyuan Zhou, Xiaxia Pan, Lanjuan Li
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4
Targeting osteopontin to treat primary sclerosing cholangitis
Kevin De Muynck, Lindsey Devisscher
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 2, pp. 77-84
Closed Access
Page 1 - Next Page

Scroll to top